Table 4.
Incidence and SHRs of gallbladder stone disease in type 1 diabetes or type 2 diabetes cohort compared with the corresponding control cohort, based on the competing risk regression.
| Type 1 diabetes | Type 2 diabetes | |||
|---|---|---|---|---|
| No | Yes | No | Yes | |
| (N = 28,060) | (N = 7,015) | (N = 51,689) | (N = 51,689) | |
| Crude SHR (95% CI) | 1 (Reference) | 0.68 (0.41, 1.13) | 1 (Reference) | 1.65 (1.54, 1.76)*** |
| Adjusted SHR(95% CI) | 1 (Reference) | 0.49 (0.25, 0.93)* | 1 (Reference) | 1.69 (1.55, 1.85)*** |
Crude SHR, relative subhazard ratio; Adjusted SHR†: multivariate analysis including age, sex, hypertension, hyperlipidemia, cirrhosis, stroke, coronary artery disease, chronic kidney diseases, alcohol-related illness, obesity, and number of parity;
P < 0.05,
P < 0.001.